Shares of Delek US Holdings, Inc. (NYSE:DK - Get Free Report) have been assigned a consensus recommendation of "Hold" from the fifteen brokerages that are presently covering the firm, Marketbeat reports. One investment analyst has rated the stock with a sell rating, seven have assigned a hold rating, six have issued a buy rating and one has issued a strong buy rating on the company. The average 1 year price target among analysts that have issued ratings on the stock in the last year is $53.1538.
A number of equities research analysts have weighed in on DK shares. Weiss Ratings upgraded Delek US from a "sell (d+)" rating to a "hold (c+)" rating in a research report on Thursday, August 6th. Citigroup reaffirmed a "neutral" rating on shares of Delek US in a report on Thursday, August 6th. TD Cowen upped their price target on shares of Delek US from $58.00 to $76.00 and gave the company a "buy" rating in a report on Tuesday, July 21st. Morgan Stanley upped their price target on shares of Delek US from $41.00 to $45.00 and gave the company an "equal weight" rating in a report on Friday, June 12th. Finally, The Goldman Sachs Group lifted their price objective on shares of Delek US from $73.00 to $83.00 and gave the stock a "buy" rating in a research note on Tuesday, August 18th.
Read Our Latest Report on Delek US
Delek US News Summary
Here are the key news stories impacting Delek US this week:
- Positive Sentiment: Zacks Research raised its 2026 EPS forecast to $7.94 from $2.22 and its 2027 forecast to $3.26 from $2.21. The firm also increased estimates for Q3 2026 to $1.77, Q4 2026 to $0.61, Q2 2027 to $0.84, Q3 2027 to $0.93 and Q4 2027 to $1.08. These revisions suggest analysts expect stronger near-term refining and downstream profitability. Delek US stock information
- Positive Sentiment: Zacks maintained a “Strong-Buy” rating on Delek US. The company’s latest quarterly results also provide momentum: EPS of $5.48 beat consensus by $2.81, while revenue increased 47.9% year over year to $4.09 billion.
- Positive Sentiment: Analysts also lifted the Q1 2028 EPS estimate to $0.57 from a projected loss of $0.26, and raised the Q4 2027 estimate to $1.08 from $0.86. Delek continues to pay a quarterly dividend of $0.255, or $1.02 annualized, although the approximately 1.4% yield is not the main driver of the recent move.
Delek US Trading Up 2.8%
NYSE:DK opened at $72.26 on Friday. The stock has a market cap of $4.42 billion, a price-to-earnings ratio of 20.30, a PEG ratio of 1.39 and a beta of 0.57. The company has a debt-to-equity ratio of 7.53, a quick ratio of 0.47 and a current ratio of 0.76. Delek US has a 1 year low of $25.85 and a 1 year high of $73.39. The business has a fifty day moving average of $60.72 and a 200-day moving average of $48.72.
Delek US (NYSE:DK - Get Free Report) last posted its quarterly earnings data on Wednesday, August 5th. The oil and gas company reported $5.48 earnings per share for the quarter, topping the consensus estimate of $2.67 by $2.81. The business had revenue of $4.09 billion during the quarter, compared to the consensus estimate of $3.44 billion. Delek US had a net margin of 1.86% and a return on equity of 109.03%. The company's quarterly revenue was up 47.9% compared to the same quarter last year. During the same quarter in the prior year, the company posted ($0.56) earnings per share. Equities analysts predict that Delek US will post 11.05 earnings per share for the current year.
Delek US Dividend Announcement
The firm also recently announced a quarterly dividend, which was paid on Monday, August 10th. Investors of record on Monday, August 3rd were issued a dividend of $0.255 per share. This represents a $1.02 dividend on an annualized basis and a yield of 1.4%. The ex-dividend date was Monday, August 3rd. Delek US's dividend payout ratio (DPR) is presently 28.65%.
Insider Transactions at Delek US
In related news, Director Gary M. Jr. Sullivan sold 27,688 shares of the stock in a transaction on Monday, August 24th. The stock was sold at an average price of $69.01, for a total value of $1,910,748.88. Following the completion of the transaction, the director owned 32,004 shares in the company, valued at $2,208,596.04. This trade represents a 46.38% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, Director William J. Finnerty sold 5,000 shares of Delek US stock in a transaction dated Monday, June 29th. The stock was sold at an average price of $51.50, for a total value of $257,500.00. Following the completion of the transaction, the director directly owned 34,805 shares in the company, valued at $1,792,457.50. This represents a 12.56% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold a total of 151,077 shares of company stock valued at $9,929,931 in the last 90 days. 3.56% of the stock is owned by corporate insiders.
Institutional Inflows and Outflows
Hedge funds and other institutional investors have recently made changes to their positions in the company. Royal Bank of Canada raised its holdings in shares of Delek US by 18.4% during the first quarter. Royal Bank of Canada now owns 278,774 shares of the oil and gas company's stock valued at $4,201,000 after acquiring an additional 43,379 shares during the period. AQR Capital Management LLC acquired a new position in Delek US in the 1st quarter worth approximately $390,000. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its position in Delek US by 3.1% during the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 37,190 shares of the oil and gas company's stock worth $560,000 after purchasing an additional 1,102 shares in the last quarter. Jones Financial Companies Lllp raised its stake in Delek US by 3,979.8% during the 1st quarter. Jones Financial Companies Lllp now owns 20,399 shares of the oil and gas company's stock valued at $307,000 after purchasing an additional 19,899 shares during the period. Finally, UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC raised its stake in Delek US by 7.2% during the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 146,871 shares of the oil and gas company's stock valued at $2,213,000 after purchasing an additional 9,827 shares during the period. 97.01% of the stock is currently owned by institutional investors and hedge funds.
About Delek US
(
Get Free Report)
Delek US Holdings, Inc NYSE: DK is an independent downstream energy company engaged in the refining, logistics, and marketing of petroleum products. Headquartered in Brentwood, Tennessee, the company operates a network of inland refineries, storage terminals and pipelines, and convenience store locations. Delek US focuses on converting crude oil into a variety of finished products, including gasoline, diesel, jet fuel, asphalt and renewable fuels, serving wholesale and retail customers across the United States.
In its refining segment, Delek US owns and operates four inland refineries located in Texas and Arkansas.
See Also

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider Delek US, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Delek US wasn't on the list.
While Delek US currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Robotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries. "Physical AI" is coming. Learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.
Get This Free Report